Earnings growth forecast for next year: Cortigent Medical (CRGT)
Cortigent, Inc. creates unique neural interfaces using patented electrode implantation methods to restore bodily functions. The expected EPS change for the coming year visualizes the analyst consensus, where shows the current value of the metric. However, the lack of revenue due to the R&D stage blocks margin growth, and the company's financial stability is entirely dependent on the outcomes of clinical trials.
Cortigent Inc - analytical breakdowns and key metrics (CRGT)
- share price and consensus valuation forecast:
- company stock exchange capitalization indicators:
- book capitalization indicators:
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Cortigent, Inc.|CRGT - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Cortigent|CRGT - Company Total Debt Obligations|Debt to Book Capitalization Ratio CRGT|CRGT - Company Long-Term Indebtedness|Company Short-Term Debts Cortigent|Quick Liquidity Indicator cortigent.com
- net income and valuation ratios data:
CRGT - Net Financial Result|Projected Future Earnings Cortigent, Inc.|CRGT - Price to Earnings Ratio|Future Price to Earnings cortigent.com|CRGT - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Cortigent Inc|CRGT - Operating profit before depreciation charges|Net earnings per share for the last 12 months Cortigent|CRGT - Earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months cortigent.com|CRGT - Earnings per share growth this year|Earnings growth forecast for next year Cortigent, Inc.
- issuer revenue and sales details:
Initial company analysis:CRGT, Cortigent Medical
This indicator reflects the consensus forecast for changes in earnings per share, measuring expected business efficiency through the dynamics of future income. By comparing assets based on this projected growth in earnings per share for the next fiscal year, investors assess the viability of the Cortigent, Inc. (CRGT) model, where the absence of revenue and the costs of neuroimplants make the forecast a key marker for the rate of capital expenditure.
Competing companies
Net earnings per share growth forecast for next year Biogen|Expected earnings per share growth for next year neurocrine.com (NBIX)|Net earnings per share growth forecast for next year Regencell Bioscience Holdings Limited (RGC)|AXSM (Axsome Therapeutics Inc) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year ACADIA Pharmaceuticals Inc. ACAD|Expected earnings per share trend next year XENE|Viking Therapeutics - Earnings growth forecast for next year|Expected earnings per share trend next year SUPN (supernus.com)|Catalyst Pharmaceuticals (CPRX) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Denali (DNLI)|Net earnings per share growth forecast for next year harmonybiosciences.com|BHVN (Biohaven Pharmaceutical) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year amylyx.com (AMLX)|TRVI: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Praxis Precision Medicines Inc PRAX|Consensus forecast of earnings per share growth for next year Anavex Life Sciences Corp. (AVXL)|CeriBell EEG - Earnings growth forecast for next year|Expected net earnings per share growth next year Prothena Corp|ALEC: Earnings growth forecast for next year|Projected earnings per share growth rate for next year ANNX|OMER (Omeros) - Earnings growth forecast for next year|NGNE - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year AC Immune Corp (ACIU)|Projected earnings per share increase next year VYGR|Earnings growth forecast for next year NMRA (neumoratx.com)|SCLX - Expected earnings per share growth for next year|tevogen.com - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Alpha Cognition Inc. (ACOG)|CGTX: Earnings growth forecast for next year|IKT - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year SAVA|Expected earnings per share growth for next year Assertio (ASRT)|Expected earnings per share growth for next year COYA (Coya)|Net earnings per share growth forecast for next year VTGN (VistaGen Therapeutics Inc)|Net earnings per share growth forecast for next year Ovid Therapeutics OVID|Earnings growth forecast for next year Acumen Pharma ABOS|CervoMed, Inc. - Earnings growth forecast for next year|Expected earnings per share trend next year ATHE (alteritytherapeutics.com)|CLNN (Clene Nanomedicine) - Expected earnings per share growth for next year|Expected net earnings per share growth next year PepGen Corp (PEPG)|Net earnings per share growth forecast for next year Jupiter Neurosciences Inc|Expected net earnings per share growth next year Relmada Therapeutics RLMD|Net earnings per share growth forecast for next year Annovis Bio (ANVS)|GRCE - Expected net earnings per share growth next year|Earnings growth forecast for next year AIFF (Firefly Neuroscience, Inc)|Klotho Neurosciences Inc (KLTO) - Expected net earnings per share growth next year|NeuroSense Therapeutics, Ltd. - Earnings growth forecast for next year|RVPH - Earnings growth forecast for next year|MetaVia Inc (MTVA) - Net earnings per share growth forecast for next year|NRXS - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year heliusmedical.com|PASG - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year Neuphoria (NEUP)|Consensus forecast of earnings per share growth for next year Minerva|Earnings growth forecast for next year ATHA (Athira Pharma Corp)|Expected earnings per share trend next year ADXN|Alzamend - Earnings growth forecast for next year|Cyclerion Therapeutics, Inc. (CYCN) - Expected earnings per share growth for next year|protagenic.com (PTIX) - Net earnings per share growth forecast for next year|KTTA: Projected earnings per share increase next year|Expected earnings per share growth for next year ATXI|Expected earnings per share growth for next year Brainstorm Cell (BCLI)|Expected earnings per share growth for next year CARA (Cara Therapeutics, Inc.)|Expected earnings per share growth for next year Chromocell Therapeutics Corp CHRO|Earnings growth forecast for next year ELYM (Eliem Therapeutics, Inc.)|Earnings growth forecast for next year intracellulartherapies.com ITCI|Longboard Pharmaceuticals - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Marinus Pharmaceuticals, Inc. MRNS|NKGN: Earnings growth forecast for next year|NeuroBo Pharmaceuticals Inc - Expected earnings per share trend next year|SAGE (Sage Therapeutics Inc.) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year SNPX (Neurotrope)|Net earnings per share growth forecast for next year Trevena Inc. (TRVN)|VIGL - Expected net earnings per share growth next year|Anew Medical Inc. - Expected earnings per share growth for next year|CERE (Cerevel Therapeutics, Inc.) - Net earnings per share change forecast for next year
